首页> 外国专利> Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and / or c-reactive protein in blood

Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and / or c-reactive protein in blood

机译:用于降低血液中葡萄糖,丙二醛修饰的LDL,高半胱氨酸和/或c反应蛋白水平的组合物

摘要

Disclosed is a composition for reducing the levels or level of glucose, malondialdehyde-modified LDL, homocysteine, and/or C-reactive protein in the blood. Specifically disclosed is a composition for reducing the level of at least one substance selected from the group consisting of glucose, malondialdehyde-modified LDL, homocysteine, and C-reactive protein in the blood, which comprises the following components (a) and (b): (a) at least one component selected from the group consisting of vitamin B 12 , vitamin B 6 , and folic acid; and (b) at least one component selected from the group consisting of zinc, selenium, and an antioxidant vitamin.
机译:公开了一种用于降低血液中葡萄糖,丙二醛修饰的LDL,高半胱氨酸和/或C反应蛋白的水平或水平的组合物。具体公开了一种用于降低血液中选自葡萄糖,丙二醛修饰的LDL,高半胱氨酸和C反应蛋白的至少一种物质的水平的组合物,其包含以下成分(a)和(b)。 :(a)至少一种选自维生素B 12,维生素B 6和叶酸的成分; (b)选自锌,硒和抗氧化剂维生素中的至少一种成分。

著录项

  • 公开/公告号DK2221059T3

    专利类型

  • 公开/公告日2018-03-12

    原文格式PDF

  • 申请/专利权人 NUTRI CO. LTD.;

    申请/专利号DK20080841027T

  • 发明设计人 KAWAGUCHI SUSUMU;

    申请日2008-10-23

  • 分类号A61K31/714;A61K31/07;A61K31/197;A61K31/355;A61K31/375;A61K31/385;A61K31/4188;A61K31/4415;A61K31/455;A61K31/51;A61K31/525;A61K31/593;A61K31/702;A61K33;A61K33/04;A61K33/06;A61K33/24;A61K33/30;A61K33/42;A61P3/06;A61P3/10;

  • 国家 DK

  • 入库时间 2022-08-21 12:52:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号